NPR1 and ovarian carcinoma: NPR-A expression and signaling is important for tumor growth, and a NPR-A deficiency has been shown to protect C57BL/6 mice from lung, skin and ovarian cancers, suggesting that NPR-A is a new target for cancer therapy (4).